The Politics of Blood
Ethics, Innovation and the Regulation of Risk
Seiten
2012
Cambridge University Press (Verlag)
978-0-521-19318-4 (ISBN)
Cambridge University Press (Verlag)
978-0-521-19318-4 (ISBN)
This book examines risk governance involving multi-valued human biological materials, such as blood. It focuses on how best to manage political, ethical and innovation concerns, as well as the use of precautionary and regulatory strategies, to promote blood safety.
How best to manage risk involving multi-valued human biological materials is the overarching theme of this book, which draws on the sourcing and supply of blood as a case study. Blood has ethical, social, scientific and commercial value. This multi-valuing process presents challenges in terms of managing risk, therefore making it ultimately a matter for political responsibility. This is highlighted through an examination of the circumstances that led to HIV blood contamination episodes in the US, England and France, as well as their consequences. The roles of scientific expertise and innovation in managing risks to the blood system are also analysed, as is the increased use of precautionary and legal strategies in the post-HIV blood contamination era. Finally, consideration is given to a range of policy and legal strategies that should underpin effective risk governance involving multi-valued human biological materials.
How best to manage risk involving multi-valued human biological materials is the overarching theme of this book, which draws on the sourcing and supply of blood as a case study. Blood has ethical, social, scientific and commercial value. This multi-valuing process presents challenges in terms of managing risk, therefore making it ultimately a matter for political responsibility. This is highlighted through an examination of the circumstances that led to HIV blood contamination episodes in the US, England and France, as well as their consequences. The roles of scientific expertise and innovation in managing risks to the blood system are also analysed, as is the increased use of precautionary and legal strategies in the post-HIV blood contamination era. Finally, consideration is given to a range of policy and legal strategies that should underpin effective risk governance involving multi-valued human biological materials.
Anne-Maree Farrell is Associate Professor of Law at the Faculty of Law, Monash University, Melbourne. Her research expertise lies broadly within the area of health law and policy, with a particular interest in the regulatory governance of human biological materials. She previously practised as a lawyer for over ten years, specialising in medical-related litigation.
1. Introduction; 2. The governance of the blood system; 3. Revisiting the gift relationship; 4. Professional beliefs and scientific expertise; 5. Risk and innovation; 6. The rise of the recipient; 7. The politics of precaution; 8. Regulating risk; 9. Conclusion.
Reihe/Serie | Cambridge Bioethics and Law |
---|---|
Zusatzinfo | 1 Line drawings, unspecified |
Verlagsort | Cambridge |
Sprache | englisch |
Maße | 156 x 235 mm |
Gewicht | 580 g |
Themenwelt | Recht / Steuern ► EU / Internationales Recht |
Recht / Steuern ► Privatrecht / Bürgerliches Recht ► Medizinrecht | |
ISBN-10 | 0-521-19318-4 / 0521193184 |
ISBN-13 | 978-0-521-19318-4 / 9780521193184 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Vorschriftensammlung
Buch | Softcover (2024)
C.F. Müller (Verlag)
CHF 76,95